AYTU
Aytu BioPharma, Inc.
AYTU's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over AYTU overall, supported by stronger modeled upside and stronger fundamentals.
AYTU Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Strong |
AYTU's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AYTU PE Valuation
AYTU has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AYTU Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
AYTU has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AYTU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.66 | +$0.96 |
| Q1 2026 | -$4.08 | -$3.05 |
| Q4 2025 | -$3.34 | -$1.58 |
| Q3 2025 | -$2.55 | -$1.01 |
| Q2 2025 | -$2.62 | +$0.25 |
| Q1 2025 | -$1.03 | +$1.76 |
| Q4 2024 | -$1.76 | +$2.44 |
| Q3 2024 | -$1.54 | +$4.77 |
AYTU is still losing money, but far less than before: $1.66 per share over the past year, against $85.40 at its worst in early 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over AYTU on earnings quality, reporting a profit while its opponent remains loss making.
AYTU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $16.1M | +6.4% |
| Q1 2026 | $12.4M | -33% |
| Q4 2025 | $15.2M | -6.5% |
| Q3 2025 | $13.9M | -16% |
| Q2 2025 | $15.1M | -16% |
| Q1 2025 | $18.5M | +2.6% |
| Q4 2024 | $16.2M | -29% |
| Q3 2024 | $16.6M | -25% |
AYTU's revenue is recovering but still below its 2023 peak: $16M last quarter, up 6.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4.8% | +46 points |
| Q1 2026 | -33% | -46 points |
| Q4 2025 | -13% | -2.5 points |
| Q3 2025 | -11% | -5.2 points |
| Q2 2025 | -50% | -30 points |
| Q1 2025 | 13% | +27 points |
| Q4 2024 | -10% | -21 points |
| Q3 2024 | -5.6% | +1.2 points |
AYTU's operating margin was −4.8% last quarter, up 46 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over AYTU on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over AYTU on profitability, with a higher operating margin.
AYTU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.4M | +58% |
| Q1 2026 | -$4.2M | +$2.3M |
| Q2 2025 | $2.8M | +$3.6M |
| Q1 2025 | -$6.5M | -$6.3M |
| Q2 2024 | -$788K | -108% |
| Q1 2024 | -$254K | +$2.7M |
| Q4 2023 | -$135K | +$2.3M |
| Q3 2023 | -$211K | +$8.9M |
AYTU's free cash flow has turned positive after five years mostly in the red: $3M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over AYTU on cash generation, producing positive trailing cash flow while its opponent burns cash.
AYTU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +17% | +1.8M shares |
| 1 year | +50% | +4.1M shares |
| 3 years | +296% | +9.2M shares |
| 5 years | +6884% | +12.1M shares |
AYTU has 12M diluted shares, up 50% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over AYTU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
AYTU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | -1.8x | Net Cash |
| Q1 2024 | -0.5x | Net Cash |
| Q4 2023 | -3.8x | Net Cash |
AYTU has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
AYTU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 8.0 | Oversold |
AYTU's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AYTU PE vs Healthcare Sector
AYTU has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
AYTU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.98 | 9.6% below |
| 20 week MA | $2.12 | 16% below |
| 50 week MA | $2.32 | 23% below |
| 100 week MA | $2.08 | 14% below |
| 200 week MA | $2.27 | 21% below |
AYTU is in a downtrend: it's below all five of its weekly moving averages, and 21% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over AYTU on trend strength, trading above more of its moving averages.
AYTU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $196.0 | $122.4 | -38% |
| 2021 | $122.4 | $30.4 | -75% |
| 2022 | $30.4 | $3.80 | -88% |
| 2023 | $3.80 | $2.84 | -25% |
| 2024 | $2.84 | $1.52 | -46% |
| 2025 | $1.52 | $2.45 | +61% |
| 2026 YTD | $2.45 | $1.79 | -27% |
AYTU has finished lower in five of the last six years. It's down 27% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over AYTU on returns for 2026, with the stronger performance.